ConvaTec Group (LON:CTEC) Receives “Buy” Rating from Berenberg Bank

ConvaTec Group (LON:CTEC)‘s stock had its “buy” rating reiterated by research analysts at Berenberg Bank in a report issued on Wednesday,London Stock Exchange reports. They presently have a GBX 310 ($4.00) price objective on the stock. Berenberg Bank’s target price would suggest a potential upside of 16.37% from the stock’s current price.

ConvaTec Group Trading Down 1.1 %

CTEC stock traded down GBX 3 ($0.04) during trading on Wednesday, hitting GBX 266.40 ($3.43). The company had a trading volume of 30,865,563 shares, compared to its average volume of 13,549,688. The firm has a 50-day moving average price of GBX 239.15 and a 200-day moving average price of GBX 232.91. ConvaTec Group has a 12 month low of GBX 211.80 ($2.73) and a 12 month high of GBX 295.20 ($3.81). The company has a quick ratio of 0.96, a current ratio of 2.26 and a debt-to-equity ratio of 85.32. The stock has a market cap of £6.77 billion, a price-to-earnings ratio of 44.86, a PEG ratio of 0.93 and a beta of 0.64.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.